Education
About Us
Working with TipRanks
Follow Us
MiMedx Group (MDXG)
NASDAQ:MDXG
Total Valuation
MiMedx Group has a market cap or net worth of $650.72M. The enterprise value is $507.13M.
Market Cap$650.72M
Enterprise Value$507.13M
Share Statistics
MiMedx Group has 148,566,590 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding148,566,590
Owned by Insiders2.13%
Owned by Institutions29.80%
Financial Efficiency
MiMedx Group’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 16.66%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.14
Return on Invested Capital (ROIC)16.66%
Return on Capital Employed (ROCE)0.23
Revenue Per Employee500.16K
Profits Per Employee58.04K
Employee Count837
Asset Turnover1.22
Inventory Turnover2.88
Valuation Ratios
The current PE Ratio of MiMedx Group is 20.6. MiMedx Group’s PEG ratio is 1.49.
PE Ratio20.6
PS Ratio2.39
PB Ratio3.90
Price to Fair Value3.90
Price to FCF13.71
Price to Operating Cash Flow8.75
PEG Ratio1.49
Income Statement
In the last 12 months, MiMedx Group had revenue of 418.63M and earned 48.58M in profits. Earnings per share was 0.33.
Revenue418.63M
Gross Profit345.62M
Operating Income63.89M
Pretax Income66.26M
Net Income48.58M
EBITDA82.93M
Earnings Per Share (EPS)0.33
Cash Flow
In the last 12 months, operating cash flow was 74.00M and capital expenditures -4.67M, giving a free cash flow of 69.33M billion.
Operating Cash Flow74.00M
Free Cash Flow69.33M
Free Cash Flow per Share0.47
Dividends & Yields
MiMedx Group pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.68
52-Week Price Change-45.52%
50-Day Moving Average5.29
200-Day Moving Average6.47
Relative Strength Index (RSI)24.44
Average Volume (3m)902.21K
Important Dates
MiMedx Group upcoming earnings date is May 5, 2026, Before Open (Not Confirmed).
Last Earnings DateFeb 25, 2026
Next Earnings DateMay 5, 2026
Ex-Dividend Date―
Financial Position
MiMedx Group as a current ratio of 4.32, with Debt / Equity ratio of 8.78%
Current Ratio4.32
Quick Ratio3.92
Debt to Market Cap0.02
Net Debt to EBITDA-1.73
Interest Coverage Ratio35.83
Taxes
In the past 12 months, MiMedx Group has paid 17.68M in taxes.
Income Tax17.68M
Effective Tax Rate0.27
Enterprise Valuation
MiMedx Group EV to EBITDA ratio is 10.33, with an EV/FCF ratio of 11.74.
EV to Sales2.05
EV to EBITDA10.33
EV to Free Cash Flow11.74
EV to Operating Cash Flow11.58
Balance Sheet
MiMedx Group has $166.12M in cash and marketable securities with $22.53M in debt, giving a net cash position of $143.59M billion.
Cash & Marketable Securities$166.12M
Total Debt$22.53M
Net Cash$143.59M
Net Cash Per Share$0.97
Tangible Book Value Per Share$1.51
Margins
Gross margin is 82.56%, with operating margin of 15.26%, and net profit margin of 11.60%.
Gross Margin82.56%
Operating Margin15.26%
Pretax Margin15.83%
Net Profit Margin11.60%
EBITDA Margin19.81%
EBIT Margin16.25%
Analyst Forecast
The average price target for MiMedx Group is $9.60, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$9.60
Price Target Upside119.18% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast14.77%
EPS Growth Forecast-58.90%